Oct 8, 2024

Grant

Congratulations to Dr. Yarmarkovich for receiving NIH Director's New Innovator Award!

Oct 14, 2024

Lab

The Yarmarkovich Lab moved to Cure on 345 Park Ave South. We are excited to build and find new discoveries in a ecosystem with world innovators.

Sep 3, 2024

New Member

The Yarmarkovich Lab would like to welcome Dr. Ritchlynn Aranha as a new postdoctoral fellow specializing in immunopeptidomics!

Jul 1, 2024

New Member

The Yarmarkovich Lab would like to welcome Dr. Christoph Neumayer as a new postdoctoral fellow!

Jun 12, 2024

Conference

Dr. Frank Li gave a talk about the "Exhaustive Tumor-Specific Antigen Search Reveals Actionable Non-Canonical Targets for Immunotherapy" at the NYU PCC Trainee Retreat!

Jun 1, 2024

New Member

The Yarmarkovich Lab would like to welcome Dr. Darren Taylor as a new post doctoral graduate! Dr. Taylor is a geneticist specializing in transposable elements. You can find more about him here

May 23, 2024

Conference

Our senior scientist Dr. Dellacherie gives a talk about CAR-T Libraries at the 9th annual NYU Langone Pathology Retreat!

May 21, 2024

Conference

Our senior scientist Dr. Dellacherie gave a talk on PC-CAR T cells for intracellular cancer drivers at the New York Academy of Science symposium for The Frontiers in Cancer Immunotherapy 2024!

Jan 1, 2024

Grant

The Yarmarkovich Lab has been awarded to develop new PC-CAR therapies in Chordoma in collaboration with the Snuderl Lab thanks to the support from the Chordoma Foundation and CRI!

Nov 7, 2023

Conference

Dr. Yarmarkovich, Dr. Dellacherie, and Dr. Palamenghi attends the NexTGen second annual research in Washington DC at the Children’s National Hospital Research.

Aug 23, 2023

Grant

Congratulations to Dr. Maxence Dellacherie for receiving NYU Technology Opportunities & Ventures (TOV) Therapeutics Alliance Funding to his proposal "Development of CAR-T cells targeting pan-cancer cleaved ligands involved in evasion of the immune response"

Aug 23, 2023

Grant

Congratulations to Dr. Michele Palamenghi for receiving NYU Technology Opportunities & Ventures (TOV) Therapeutics Alliance Funding to his proposal " Next-generation CAR T cells: expanding the target landscape and eligible solid tumor patient population"

Dec 6, 2022

Article

The Prostate Cancer Foundation Announces Inaugural $30 Million TACTICAL Awards Program for Innovative Prostate Cancer Research

Jun 16, 2022

Article

Announcing 4 new teams receiving $100m to take on cancer's toughest challenges

Jun 1, 2022

Conference

Dr. Yarmarkovich was invited to talk on "Breaking Restrictions in Cancer Immunotherapy: Expanding Targets and Patient Populations"

Nov 3, 2021

Article

A new class of CAR T cells targets previously untargetable cancer drivers

Nov 4, 2021

Article

New Class of “Peptide-Centric” CAR-T Cells Eradicates Tumors in Mice

Jun 8, 2020

Article

Scientists Identify Targets for COVID-19 Vaccine Using Cancer Immunotherapy Tools